Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK

Genes Chromosomes and Cancer

Volumn 50, Issue 6, 2011, Pages 434-441

  Fejzo, Marlena S ^a   Ginther, Chuck ^a   Dering, Judy ^a   Anderson, Lee ^a   Venkatesan, Natarajan ^a   Konecny, Gottfried ^a   Karlan, Beth ^b   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRMI GENE; ARTICLE; CANCER RECURRENCE; CHROMOSOME 20Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE AMPLIFICATION; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GIPC1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RECK GENE; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 79954420455     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20868     Document Type: Article

References (19)

1. Al-Shami A, Jhaver KG, Vogel P, Wilkins C, Humphries J, Davis JJ, Xu N, Potter DG, Gerhardt B, Mullinax R, Shirley CR, Anderson SJ, Oravecz T. 2010. Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. PLoS One e13654.
2. Chen W, Hu XT, Shi QL, Zhang FB, He C. 2009a. [Silencing of ADRM1 by RNA interference suppresses proliferation of colorectal cancer cells]. Zhonghua Zhong Liu Za Zhi 31: 815-819 (Chinese).
3. Chen W, Hu XT, Shi QL, Zhang FB, He C. 2009b. Knockdown of the novel proteasome subunit ADRM1 located on the 20q13 amplicon inhibits colorectal cancer cell migration, survival and tumorigenicity. Oncol Rep 21: 531b-537b.
4. Cherix N, Froquet R, Charette SJ, Blanc C, Letourneur F, Cosson P. 2006. A Phg2-ADRM1 pathway participates in the nutrient-controlled developmental response in Dictyostelium. Mol Biol Cell 17: 4982-4987.
5. Clark JCM, Thomas DM, Choong PFM, Dass CR. 2007. RECK-A newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastisis Rev 26: 675-683.
6. Edgar R, Domrachev M, Lash AE. 2002. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
7. Fejzo MS, Dering J, Ginther C, Anderson L, Ramos L, Walsh C, Karlan B, Slamon DJ. 2008. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target. Genes Chromosomes Cancer 47: 873-883.
8. Hamazaki J, Iemura S, Natsume T, Yashiroda H, Tanaka K, Murata S. 2006. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. EMBO J 25: 4524-4536.
9. Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A. 2009. Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751, 871) in combination with paclitaxel and carboplatin. J Thorac Oncol 4: 1397-1403.
10. Katoh M. 2002. GIPC gene family (Review). Int J Mol Med 9: 585-589.
11. Kirikoshi H, Katoh M. 2002. Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors. Int J Mol Med 9: 509-513.
12. Lamerant N, Kieda C. 2005. Adhesion properties of adhesion-regulating molecule 1 protein on endothelial cells. FEBS J 272: 1833-1844.
13. Muders MH, Vohra PK, Dutta SK, Wang E, Ikeda Y, Wang L, Udugamasooriya DG, Memic A, Rupasinghe CN, Baretton GB, Aust DE, Langer S, Datta K, Simons M, Spaller MR, Mukhopadhyay D. 2009. Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clin Cancer Res 15: 4095-4103.
14. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grützmann R. 2004. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750.
15. Qiu XB, Ouyang SY, Li CJ, Miao S, Wang L, Goldberg AL. 2006. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25: 5742-5753.
16. Simins AB, Weighardt H, Weidner KM, Weidle UH, Holzmann B. 1999. Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells. Clin Exp Metastasis 17: 641-648.
17. Yang JM. 2007. Emerging roles of deubiquitinating enzymes in human cancer. Acta Pharmacol Sin 28: 1325-1330.
18. Yavelsky V, Rohkin S, Shaco-Levy R, Tzikinovsky A, Amir T, Kohn H, Delgadoz B, Rabinovich A, Piura B, Chan G, Kalantarov G, Trakht I, Lobel L. 2008. Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary. BMC Cancer 8: 247.
19. Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol (in press).